Showing 43,941 - 43,960 results of 44,567 for search '(( 09 ((0 decrease) OR (a decrease)) ) OR ( 20 ((nn decrease) OR (teer decrease)) ))', query time: 0.96s Refine Results
  1. 43941

    Table_2_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.docx by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  2. 43942

    Image_8_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  3. 43943

    Image_3_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  4. 43944

    Table_4_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.docx by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  5. 43945

    Image_14_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  6. 43946

    Image_11_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  7. 43947

    Table_7_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.docx by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  8. 43948

    Table_8_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.docx by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  9. 43949

    Image_7_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  10. 43950

    Image_5_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  11. 43951

    Image_4_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG by Fang Wang (105926)

    Published 2023
    “…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
  12. 43952
  13. 43953
  14. 43954

    Low Health System Performance, Indigenous Status and Antivenom Underdosage Correlate with Spider Envenoming Severity in the Remote Brazilian Amazon by Vanderson Souza Sampaio (3167037)

    Published 2016
    “…Envenomings recorded from urban areas [Odds ratio (OR) = 0.40 (95%CI = 0.30–0.71; p<0.001)] and living in a municipality with a mean health system performance index (MHSPI >median [OR = 0.64 (95%CI = 0.39–0.75; p<0.001)] were independently associated with decreased risk of severity. …”
  15. 43955
  16. 43956

    Table_2_Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.docx by Vincent T. Ma (13003329)

    Published 2022
    “…</p>Methods<p>We performed a retrospective analysis on a cohort of patients with advanced melanoma who w0ere treated with standard I/N. …”
  17. 43957

    Table_3_Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.docx by Vincent T. Ma (13003329)

    Published 2022
    “…</p>Methods<p>We performed a retrospective analysis on a cohort of patients with advanced melanoma who w0ere treated with standard I/N. …”
  18. 43958

    Table_1_Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.docx by Vincent T. Ma (13003329)

    Published 2022
    “…</p>Methods<p>We performed a retrospective analysis on a cohort of patients with advanced melanoma who w0ere treated with standard I/N. …”
  19. 43959

    Table_4_Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.docx by Vincent T. Ma (13003329)

    Published 2022
    “…</p>Methods<p>We performed a retrospective analysis on a cohort of patients with advanced melanoma who w0ere treated with standard I/N. …”
  20. 43960

    DataSheet_1_Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome.docx by Christina-Maria Flessa (3751939)

    Published 2022
    “…The association remained significant after adjustment for the variables contributing to fatigue in the univariate analysis (OR [95% CI]: 0.3 [0.1-0.9], p=0.026). Accordingly, in the Dutch cohort, there was a trend of lower mental fatigue among patients carrying the TT rs9514828 BAFF genotype compared to their CC counterparts (4.1 ± 2.4 vs 6.0 ± 2.2 respectively, p=0.06). …”